Abstract. We have studied a family in which the proband had systemic lupus erythematosus and selective incomplete deficiency of the fourth component of complement (C4) (2-5% of the normal level). An additional six healthy family members also had low C4 levels (2.4-24.1% of normal) but no evidence of lupus. This form of inherited C4 deficiency differs from that in previously reported families in that inheritance was autosomal dominant (rather than recessive), C4 levels were markedly reduced (but not undetectable), and there was no linkage to HLA, BF, or C4 structural loci, all known to be within the major histocompatibility complex.
Introduction
Nine unrelated individuals have been described who lack detectable levels of the fourth component of serum complement (C4)' by functional and immunochemical measurements. The first patient, described by Hauptmann and co-workers (I), was an 18-yr-old girl with systemic lupus erythematosus. HLA Dr. Ratnoff is a Career Investigator of the American Heart Association.
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1. Abbreviations used in this paper: C4, fourth component of complement; CH50, hemolytic complement; CIC, circulating immune complexes; PG4M3, phosphoglucomutase-3. typing ofthis family suggested linkage between the C4-deficiency gene and the major histocompatibility complex (MHC) (2) . Most subsequent cases of C4 deficiency (3-10) have had systemic lupus or lupuslike disease.
C4 in man is synthesized under the direction of two distinct but very closely linked loci (11) , designated C4A and C4B. Half-null haplotypes containing C4A*QO (quantity zero) or C4B*QO are common in caucasians (12) and can best be detected in family studies by neuraminidase treatment of serum or plasma and crossed immunoelectrophoresis (13). By immunofixation ofagarose gel electrophoresis of neuraminidasetreated samples, extensive structural genetic polymorphism can be recognized at both the C4A and C4B loci (14) . The products of C4A and C4B differ in serological reactivity in that C4A variants are Rodgers positive and C4B variants are Chido positive (12) . Under certain conditions, C4B has hemolytic activity whereas C4A does not (14) . In general, C4A variants tend to be more acidic than C4B variants and the chain of C4A variants is of slower mobility than that of C4B variants on sodium dodecyl sulfate (SDS) gel electrophoresis (15) .
When C4 typing was performed in a family with a child with classical C4 deficiency (16) , it was shown conclusively that the deficiency resulted from homozygosity for a doublenull C4 haplotype, C4A*QO, C4B*QO, closely linked to other loci of the MHC, including HLA. Subsequent studies have confirmed these findings (10, 17) .
We have studied a 26-yr-old woman with lupus erythematosus and persistent hypocomplementemia. She appears to have a selective incomplete deficiency of C4. Her erythrocytes were positive for Rodgers and Chido antigens. 22 (18) and for C3 through C9 by the methods of Nelson et al. (19) , as modified by Rosenfeld et al. (20) . Hemolytic titrations of Cl and C4 were also performed on mixtures of normal human serum and serum from the proband drawn during a period of inactive disease. The concentrations of factor B, prosperdin, #-1-H, C4 binding protein, and C1 inhibitor were determined by electroimmunoassay (21). Cl inhibitor was also measured by an esterolytic assay (22) and its charge was analyzed by immunofixation after agarose gel electrophoresis. Sera were tested for circulating immune complexes (CIC) by the method of Zubler et al. (23) .
Analysis of C4, BF, and HLA haplotypes. Desialated plasma samples were subjected to crossed immunoelectrophoresis for detection of null alleles at the C4A and C4B loci, as described previously (13). To detect C4 structural variants, desialated plasma samples were subjected to immunofixation electrophoresis in 0.75% agarose as previously described (14) . C4 subunit size was analyzed by immunoprecipitation with anti-C4 on SDS-polyacrylamide gels (15) . HLA typing for antigens at the HLA-A, B, C, and D loci was performed by a modified micromethod (24) . The method for isolating B lymphocytes was according to Lowry (25) . Plasma samples were subjected to agarose gel electrophoresis and immunofixation (26) with goat antiserum to human factor B (Atlantic Antibodies, Scarborough, ME) for BF typing. C2 types were determined by isoelectric focusing (27 
Results
The concentration of C4 in the proband's serum measured functionally over a 2-yr period was 2-5% of normal and as antigen it was 3-9% of normal. Antigenic C4 levels in EDTA plasma samples maintained at 370C were 5-10% of normal. Table I presents the results of complement studies performed No family members, except the proband, had clinical evidence of immune complex disease, and sera from family members were all negative for CIC (except for one). In the proband, CIC were detectable only during periods of increased lupus activity. However, decreased C4 levels in the proband were unrelated to CIC and/or level of disease activity. Lowlevel CIC were detected in only one family member (II-6). These were transient, and were not associated with clinical disease or decreased levels of C3 or C4. Because of the clinical abnormalities of the proband in this study, a comprehensive evaluation of hemostasis was performed (Table II) . No abnormalities were detected except a reduced titer of Hageman factor (Factor XII), which was 56% of normal. Since her mother also had an intermediate titer of Hageman factor, the patient may be a heterozygote for Hageman factor deficiency.
Because the low C4 concentration in the proband's plasma might be explained by an uninhibited proteolytic attack on C4, a number of protease inhibitors were studied in the patient's plasma or serum. The concentrations of CG inhibitor, a1-antitrypsin, a1-antichymotrypsin, a2-macroglobulin, a2-antiplasmin, and antithrombin III were all within normal limits (Table HI) Studies in the patient's family revealed that six other members had hemolytic and immunochemical C4 concentrations below the normal range defined as the mean value±2 SD (Table IV) . It is evident from the pedigree that the individuals with low C4 levels occurred in four subfamilies, all on the paternal side (Fig. 1) . A paternal uncle (1-5) had an even lower serum C4 concentration than the proband. Of the father's three living siblings, two had C4 deficiency. One of two children of a deceased paternal uncle had C4 deficiency as did the patient's brother. Two of seven of the affected paternal uncle's children also had C4 deficiency. Thus, in this family, six of thirteen of the patient's relatives at risk, four males and two females, had C4 deficiency and there was maleto-male transmission of this trait. The pattern of inheritance is thus most likely autosomal dominant.
No evidence for linkage between C4 deficiency as a dominant trait and the MHC or other sixth chromosome markers could be obtained. In particular, there was neither linkage nor any association whatsoever between C4 genetic types and C4 deficiency. Although almost all affected individuals had one (of four) null C4 alleles and one (1-6) had two, this was also true of many family members with normal C4 levels.
Discussion
The form of C4 deficiency in the present family differs strikingly from that in previously described families (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) a number of ways. In the previous families, C4 deficiency was complete and C4 was not detectable either functionally or immunochemically. In the present family, some C4 was found in the serum of each affected individual and was present at concentrations of 2-24% of normal. Immunofixation and SDS-PAGE studies indicate that the net surface change on the C4 molecule was as predicted from the allotypes and family studies and that no major glycosylation difference was present. In "classical" C4 deficiency, inheritance is recessive and carriers have, on average, about 50% of normal levels, although the range is so wide that serum concentration alone is a poor guide to detecting heterozygotes (3, 16) in such families. Classic C4 deficient individuals have inherited two double-null C4 halplotypes (C4A*QO; C4B*QO) (16) . However, the form of C4 deficiency described here is inherited as a dominant trait, is independent of C4 structural gene types and null alleles and is not linked to the MHC or other closely associated loci of the sixth human chromosome. The present patient, like those with classical C4 deficiency, has systemic lupus erythematosus. However, the six relatives of our patient with decreased C4 have no signs of lupus or other collagen-vascular disease, suggesting that the association is by chance in this family. Studies of the coagulation system in this family revealed only that the proband and her mother were probable heterozygotes for Hageman factor deficiency. Since there was no correlation between this abnormality and C4 levels in the family, it must be regarded as coincidental.
The only previously recognized complement deficiency state to be inherited as an autosomal dominant trait is hereditary angioneurotic edema (36) and it is associated with reduced C4 levels. Therefore, care was taken to exclude this possibility in the present family. No family member had experienced any symptoms of angioneurotic edema. C! inhibitor serum concentrations were normal by immunochemical and functional assays and had normal electrophoretic mobility (37) in all family members. Functionally measured C2 levels were normal in all subjects. C4 was in its native state in serum from all deficient persons. These observations make it unlikely that an abnormal C1 inhibitor molecule is the cause of C4 deficiency in this family. The slightly reduced C4 binding protein concentrations in the serum of some individuals with markedly reduced C4 levels suggest C4 consumption by some uninhibited protease as the basis of the abnormality. However, the concentrations of a number of protease inhibitors such as a1-antitrypsin, a,-antichymotrypsin, a2-antiplasmin, antithrombin III, and a2-macroglobulin were normal in all sera from affected individuals.
